Literature DB >> 10844636

Many cell types are Shiga toxin targets.

K E Meyers, B S Kaplan.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10844636     DOI： 10.1046/j.1523-1755.2000.00126.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

1.  Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.

Authors:  Bianfang Liu; Xianhua Yin; Yanni Feng; James R Chambers; Aiguang Guo; Joshua Gong; Jing Zhu; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence.

Authors:  Bridget R Kulasekara; Michael Jacobs; Yang Zhou; Zaining Wu; Elizabeth Sims; Channakhone Saenphimmachak; Laurence Rohmer; Jennifer M Ritchie; Matthew Radey; Matthew McKevitt; Theodore Larson Freeman; Hillary Hayden; Eric Haugen; Will Gillett; Christine Fong; Jean Chang; Viktoriya Beskhlebnaya; Matthew K Waldor; Mansour Samadpour; Thomas S Whittam; Rajinder Kaul; Mitchell Brittnacher; Samuel I Miller
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

5.  Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases.

Authors:  Joyce C Y Ching; Nicola L Jones; Peter J M Ceponis; Mohamed A Karmali; Philip M Sherman
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 6.  Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.

Authors:  Elias A Rahal; Natalie Kazzi; Farah J Nassar; Ghassan M Matar
Journal:  Front Cell Infect Microbiol       Date:  2012-11-15       Impact factor: 5.293

7.  tHe USual Suspects.

Authors:  Peter Maginnis; John Anderton; Beena Nair; Alexander Woywodt
Journal:  NDT Plus       Date:  2011-03-31

Review 8.  Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.

Authors:  E E Bowen; R J Coward
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-22

9.  Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.

Authors:  Julia Doulgere; Benjamin Otto; Maher Nassour; Gerrit Wolters-Eisfeld; Holger Rohde; Tim Magnus; Christoph Wagener; Thomas Streichert
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.